TITLE

Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy

AUTHOR(S)
Asante, Kwaku P.; Abokyi, Livesy; Zandoh, Charles; Owusu, Ruth; Awini, Elizabeth; Sulemana, Abubakari; Amenga-Etego, Seeba; Adda, Robert; Boahen, Owusu; Segbaya, Sylvester; Mahama, Emmanuel; Bart-Plange, Constance; Chandramohan, Daniel; Owusu-Agyei, Seth
PUB. DATE
January 2010
SOURCE
BMC Public Health;2010, Vol. 10, p409
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Artesunate-amodiaquine (AS-AQ) was introduced in Ghana as the first line drug for treatment of uncomplicated malaria in 2004. We report the perceptions of malaria and malaria treatment behaviour, the community awareness of and perceptions about AS-AQ two years after the introduction of this ACT treatment for malaria. Methods: Two surveys were conducted; a cross-sectional survey of 729 randomly selected household heads (urban-362, rural-367) and 282 women with children < 5 years (urban-121, rural-161) was conducted in 2006. A district wide survey was conducted in 2007 to assess awareness of AS-AQ. These were complemented with twenty-eight focus group discussions (FGDs) and 16 key informant interviews (KII) among community members and major stakeholders in the health care delivery services. All nine (9) health facilities and five (5) purposively selected drug stores were audited in order to identify commonly used anti-malarials in the study area at the time of the survey. Results: Majority of respondents ( > 75%) in the sampled survey mentioned mosquito bites as the cause of malaria. Other causes mentioned include environmental factors (e.g. dirty surroundings) and standing in the sun. Close to 60% of the household heads and 40% of the care-givers interviewed did not know about AS-AQ. The community respondents who knew about and had ever taken AS-AQ perceived it to be a good drug; although they mentioned they had experienced some side effects including headaches and body weakness. Co-blistered AS-AQ was available in all the government health facilities in the study area. Different formulations of ACTs were however found in urban chemical shops but not in rural chemical stores where monotherapy antimalarials were predominant. Conclusion: The knowledge of fever as a symptom of malaria is high among the study population. The awareness of AS-AQ therapy and its side-effect was low in the study area. Community education and sensitization, targeting all categories of the population, has to be intensified to ensure an efficient implementation process.
ACCESSION #
52840536

 

Related Articles

  • Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Achan, Jane; Talisuna, Ambrose O.; Erhart, Annette; Yeka, Adoke; Tibenderana, James K.; Baliraine, Frederick N.; Rosenthal, Philip J.; D'Alessandro, Umberto // Malaria Journal;2011 Supplement 1, Vol. 10 Issue Suppl 1, p144 

    Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented. However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs. This...

  • ARTEMISININS AND SYNTHETIC PEROXIDES AS HIGHLY EFFICIENT ANTIMALARIALS. Opsenica, Dejan M.; Šolaja, Bogdan A. // Macedonian Journal of Chemistry & Chemical Engineering;2012, Vol. 31 Issue 2, p137 

    Malaria is devastating disease and global public health problem, with nearly half world population exposed to risk. Illness is caused by five Plasmodium species, P. falciparum, P. ovale, P. vivax, P. malaria and P. knowlesi, from which P. falciparum is the most serious one causing cerebral...

  • Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis.  // Malaria Journal;2012, Vol. 11 Issue 1, p2 

    The article focuses on a systematic review and meta-analysis regarding the efficacy of the combining of quinine and clindamycin for the treatment of falciparum malaria. In the study, randomized controlled trials are conducted to compare the treatment of malaria with quinine and clindamycin in...

  • Population Pharmacokinetics and Pharmacodynamics of Piperaquine in Children With Uncomplicated Falciparum Malaria. Tarning, J; Zongo, I; Somé, F A; Rouamba, N; Parikh, S; Rosenthal, P J; Hanpithakpong, W; Jongrak, N; Day, N P J; White, N J; Nosten, F; Ouedraogo, J-B; Lindegardh, N // Clinical Pharmacology & Therapeutics;Mar2012, Vol. 91 Issue 3, p497 

    Dihydroartemisinin-piperaquine is being increasingly used as a first-line artemisinin combination treatment for malaria. The aim of this study was to describe the pharmacokinetic and pharmacodynamic properties of piperaquine in 236 children with uncomplicated falciparum malaria in Burkina Faso....

  • Evidence Update.  // Africa Health;Sep2011, Vol. 33 Issue 6, p32 

    The article discusses the findings of a study regarding the efficacy of using artesunate, an antimalaria derived from artemisinin, instead of quinine for treating severe malaria. It provides an overview of the disease and the role of artesunate in the treatment of the disease. It mentions the...

  • A Novel Flow Cytometric Hemozoin Detection Assay for Real-Time Sensitivity Testing of Plasmodium falciparum. Rebelo, Maria; Sousa, Claudia; Shapiro, Howard M.; Mota, Maria M.; Grobusch, Martin P.; Hänscheid, Thomas // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Resistance of Plasmodium falciparum to almost all antimalarial drugs, including the first-line treatment with artemisinins, has been described, representing an obvious threat to malaria control. In vitro antimalarial sensitivity testing is crucial to detect and monitor drug resistance. Current...

  • New Perspectives for Adjuvant Therapy in Severe Malaria. Prato, Mauro; Giribaldi, Giuliana // Journal of Bacteriology & Parasitology;2012, Vol. 3 Issue 5, p1 

    The authors reflect on the importance of developing fast acting drugs to treat severe malaria. They offer information on malaria which is a common parasitic disease that leads to an estimated of one million deaths annually that mainly affects young children. They discuss the treatment for...

  • Advances in the Treatment of Malaria. Castelli, Francesco; Tomasoni, Lina Rachele; Matteelli, Alberto // Mediterranean Journal of Hematology & Infectious Diseases;2012, Vol. 4 Issue 1, p1 

    Malaria still claims a heavy toll of deaths and disabilities even at the beginning of the third millennium. The inappropriate sequential use of drug monotherapy in the past has facilitated the spread of drug-resistant P falciparum, and to a lesser extend P vivax, strains in most of the malaria...

  • Synergistic anti-malarial action of cryptolepine and artemisinins. Forkuo, Arnold D.; Ansah, Charles; Boadu, Kwesi M.; Boampong, Johnson N.; Ameyaw, Elvis O.; Gyan, Ben A.; Arku, Andrea T.; Ofori, Michael F. // Malaria Journal;2/16/2016, Vol. 15, p1 

    Background: Cryptolepine (CPE) is the major indoloquinoline isolated from the popular West African anti-malarial plant, Cryptolepis sanguinolenta. CPE possesses various pharmacological activities with potent anti-malarial activity against both chloroquine (CQ)-resistant and -sensitive strains....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics